5 of Last Week's Biggest Winners
These five stocks posted double-digit percentage gains this past week.
This Week in Biotech: Clinical Success, Plus Wheeling and Dealing
Two positive clinical results, a symbiotic asset deal, and a rumored takeover target are this week's top stories in Part 2 of "This Week in Biotech."
3 Humongous Health-Care Stocks This Week
Why Ariad, Prana, and Geron enjoyed humongous gains this week.
Why BioDelivery Sciences, Ariad Pharmaceuticals, and Juniper Networks Are Today's 3 Best Stocks
The S&P 500 dives more than 2% on domestic and overseas growth concerns, while BioDelivery Sciences, Ariad Pharmaceuticals, and Juniper Networks buck the trend in a big way.
Why Ariad Pharmaceuticals Inc. Shares Soared
The rumor mill is working overtime today on Ariad Pharmaceuticals thanks to a London newspaper article. Should shareholders jump or balk at this report?